» Articles » PMID: 34801085

Caspase-3/NLRP3 Signaling in the Mesenchymal Stromal Niche Regulates Myeloid-biased Hematopoiesis

Overview
Publisher Biomed Central
Date 2021 Nov 21
PMID 34801085
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The fate of hematopoietic stem cells (HSCs) is determined by a complex regulatory network that includes both intrinsic and extrinsic signals. In the past decades, many intrinsic key molecules of HSCs have been shown to control hematopoiesis homeostasis. Non-hematopoietic niche cells also contribute to the self-renewal, quiescence, and differentiation of HSCs. Mesenchymal stromal cells (MSCs) have been identified as important components of the niche. However, the regulatory role of MSCs in hematopoiesis has not been fully understood.

Methods: Caspase-3 and NLRP3 gene knockout mice were generated respectively, and hematopoietic development was evaluated in the peripheral circulation and bone marrow by flow cytometry, colony formation assay, and bone marrow transplantation. Bone-associated MSCs (BA-MSCs) were then isolated from gene knockout mice, and the effect of Caspase-3/NLRP3 deficient BA-MSCs on hematopoiesis regulation was explored in vivo and ex vivo.

Results: We report that Caspase-3 deficient mice exhibit increased myelopoiesis and an aberrant HSC pool. Ablation of Caspase-3 in BA-MSCs regulates myeloid lineage expansion by altering the expression of hematopoietic retention cytokines, including SCF and CXCL12. Interestingly, NLRP3 gene knockout mice share phenotypic similarities with Caspase-3 deficient mice. Additionally, we found that NLRP3 may play a role in myeloid development by affecting the cell cycle and apoptosis of hematopoietic progenitors.

Conclusions: Our data demonstrate that the Caspase-3/NLRP3 signaling functions as an important regulator in physiological hematopoiesis, which provides new insights regarding niche signals that influence hematopoiesis regulation in the bone marrow.

Citing Articles

Inflammasomes: potential therapeutic targets in hematopoietic stem cell transplantation.

Luo J, Zhou Y, Wang M, Zhang J, Jiang E Cell Commun Signal. 2024; 22(1):596.

PMID: 39695742 PMC: 11657697. DOI: 10.1186/s12964-024-01974-3.


Loss of PADI2 and PADI4 ameliorates sepsis-induced acute lung injury by suppressing NLRP3+ macrophages.

Yu X, Song Y, Dong T, Ouyang W, Shao L, Quan C JCI Insight. 2024; 9(22).

PMID: 39405117 PMC: 11601939. DOI: 10.1172/jci.insight.181686.


Clodronate liposomes may biases MSC differentiation toward adipogenesis through activation of NLRP3.

Ding S, Wang Y, Liu Z, Du Y, Zhou Y, Liu Y Regen Ther. 2023; 24:54-63.

PMID: 37868719 PMC: 10584668. DOI: 10.1016/j.reth.2023.05.001.


NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease.

Chen Y, Meng W, Ren G, An N, Zhang J, Liu Z Heliyon. 2023; 9(7):e18038.

PMID: 37483815 PMC: 10362138. DOI: 10.1016/j.heliyon.2023.e18038.


Mechanism of NLRP3 inflammasome intervention for synovitis in knee osteoarthritis: A review of TCM intervention.

Han X, Lin D, Huang W, Li D, Li N, Xie X Front Genet. 2023; 14:1159167.

PMID: 37065495 PMC: 10090545. DOI: 10.3389/fgene.2023.1159167.


References
1.
Kaushansky K, Zhan H . The marrow stem cell niche in normal and malignant hematopoiesis. Ann N Y Acad Sci. 2019; 1466(1):17-23. PMC: 6814507. DOI: 10.1111/nyas.14028. View

2.
Paugh S, Bonten E, Savic D, Ramsey L, Thierfelder W, Gurung P . NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells. Nat Genet. 2015; 47(6):607-14. PMC: 4449308. DOI: 10.1038/ng.3283. View

3.
Morrison S, Scadden D . The bone marrow niche for haematopoietic stem cells. Nature. 2014; 505(7483):327-34. PMC: 4514480. DOI: 10.1038/nature12984. View

4.
Hurwitz S, Jung S, Kurre P . Hematopoietic stem and progenitor cell signaling in the niche. Leukemia. 2020; 34(12):3136-3148. DOI: 10.1038/s41375-020-01062-8. View

5.
Anthony B, Link D . Regulation of hematopoietic stem cells by bone marrow stromal cells. Trends Immunol. 2013; 35(1):32-7. PMC: 3947365. DOI: 10.1016/j.it.2013.10.002. View